Dexrazoxane is primarily used in oncology to protect the heart from damage during treatment with anthracycline drugs. It is approved for use in patients with metastatic breast cancer and is also considered for children receiving high doses of these drugs. Additionally, dexrazoxane has been investigated for its potential to protect against other types of tissue damage, such as extravasation injuries caused by vesicant chemotherapeutic agents.
